Abstract
BackgroundAVID and MADIT-II trials showed that patients with coronary artery disease taking HMG-CoA reductase inhibitors have fewer ICD shocks suggesting anti-arrhythmic effects. Our aim was to analyze the effects of...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have